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Abstract
Introduction: Holmium laser enucleation of the prostate (HoLEP) combined with mechanical
morcellation represents the latest refinement of holmium:YAG surgical treatment for benign
prostatic hyperplasia (BPH). Utilizing this technique, even the largest of glands can be effectively
treated with minimal morbidity. The learning curve remains an obstacle, preventing more
widespread adoption of this procedure. This paper provides an outline of the HoLEP technique as
is currently used at two centers in hopes of easing the initial learning curve.
Technical considerations: Detailed descriptions of the major steps of the HoLEP procedure are
provided with attention to critical steps such as identification of the surgical capsule, median and
lateral lobe enucleation, and morcellation of enucleated tissue.
Conclusions: HoLEP is a promising alternative for the surgical treatment of BPH which allows
complete removal of intact lobes of the prostate. Obstruction is relieved immediately with superior
hemostasis, no risk of TUR syndrome, and a minimal hospital stay.
Introduction
Benign prostatic hyperplasia (BPH), which is prevalent in
up to 43% of men over the age of 60[1], continues to be a
leading cause of voiding difficulties. Symptoms generally
worsen with age, with men experiencing a mean increase
of the American Urological Association (AUA) symptom
score of 0.18 points per year of follow-up[2] Although
symptoms can often be handled adequately with medical
therapy, patients who continue to suffer significant void-
ing problems will eventually require surgical intervention
to avoid or treat long-term sequelae such as urinary reten-
tion, urinary tract infections, and bladder calculi.
When surgical treatment is considered, transurethral
resection of the prostate (TURP) is still the standard to
which all other modalities are compared. Although the
morbidity associated with TURP can be low when per-
formed by experienced surgeons, complications such as
TUR syndrome and bleeding can still occur. For this rea-
son, many alternative energy modalities have been devel-
oped in an attempt to not only provide an effective
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surgical treatment for BPH, but also to minimize the risk
of complications and the length of hospital stays.
One such technological advance involves the hol-
mium:YAG laser. This laser has found widespread uro-
logic applications, especially in the treatment of
urolithiasis[3] Because the laser's wavelength is highly
absorbed by water[4], it is also an effective tool for the
ablation and cutting of soft tissue. These characteristics
naturally extend into applications for BPH.
Use of the holmium:YAG laser in the treatment of BPH
has changed significantly over the past five years. As tech-
niques have been refined and equipment improved, the
spectrum of treatment has progressed from simple vapor-
ization of tissue to the complete removal, or enucleation,
of intact lobes of prostatic adenoma. At the present time,
holmium laser enucleation of the prostate (HoLEP) com-
bined with mechanical morcellation represents the latest
refinement of the resection technique. By utilizing this
procedure, even extremely large glands which previously
would have required an open simple prostatectomy can
be treated effectively, with only an overnight stay for the
patient. In our experience, the largest gland we have
treated successfully with HoLEP had a specimen weight of
376 grams after morcellation (unpublished data).
Although HoLEP is a promising alternative for the surgical
treatment of BPH, the learning curve for the procedure
remains a significant obstacle. The purpose of this paper
is to review the development of HoLEP and present a step-
wise outline of the procedure, with a complete list of nec-
essary equipment and attention to critical points during
the enucleation process. It is hoped that this description
of HoLEP will help to flatten the learning curve for urolo-
gists interested in learning this procedure.
Background
Historical development of HoLEP
The holmium:YAG laser (2140 nm) acts through a pre-
dominantly photothermal mechanism.[5] Because it is
capable of vaporizing soft tissue, application of the hol-
mium laser for BPH first focused on sequential ablation of
tissue in order to enlarge a channel through the prostate.
Initially, treatment with the holmium laser was per-
formed in association with the neodymium (Nd:YAG)
laser, in a technique known as combination endoscopic
laser ablation of the prostate (CELAP)[6] It was hoped
that the holmium laser would be able to reduce the short-
term sequelae of Nd:YAG coagulation prostatectomy,
which included prolonged catheterization and delayed
symptomatic improvement [7]
With CELAP, a circumferential coagulation of prostatic tis-
sue was first performed using the Nd:YAG laser, followed
by vaporization of an adequately sized channel using hol-
mium energy. Unfortunately, this combination procedure
was still associated with significant indwelling catheteri-
zation times postoperatively, ranging from 4.1 to 7.1
days.[6,8] In addition, many patients required re-catheter-
ization for urinary retention and also had irritative void-
ing symptoms[4,9]
As more clinical experience with the holmium laser was
gained, it became apparent that the laser had sufficient
hemostatic effects when used to vaporize soft tissue on its
own, without the addition of the Nd:YAG component[4]
Further evidence of the effectiveness of the holmium laser
on prostate tissue was provided by canine and human
studies by Kabalin, who showed that hemostatic vaporiza-
tion occurred using high powers ranging from 50 to 80
watts[10,11] As a result, holmium laser ablation of the
prostate, termed HoLAP, was developed, which elimi-
nated many of the short-term voiding problems associ-
ated with use of the Nd:YAG laser.
The main advantage of HoLAP was the ease in learning the
procedure. One disadvantage, however, was the lack of tis-
sue availability for pathologic analysis. In addition, the
procedure was considered cumbersome, mainly because
of the slow process of tissue vaporization. In a rand-
omized comparison of holmium vaporization versus
TURP, Mottet, et al, showed that the laser procedure
required a significantly longer time (75 vs. 56 minutes) to
achieve prostatic defects comparable to those in the TURP
patients[12] For this reason, HoLAP was considered use-
ful only for smaller glands. In order to achieve more effi-
ciency, attention then turned to developing a method of
removing larger portions of adenoma.
The first description of holmium laser resection of the
prostate (HoLRP) was reported by Gilling, et al in
1996[13] This technique was the first to utilize the cutting
properties of the holmium laser to detach large sections of
adenoma tissue. A major advantage is that normal saline
could be used as the irrigation fluid, which eliminates the
risk of TUR syndrome during resection. During a HoLRP,
the median lobe is resected first, followed by the lateral
lobes. Because tissue needs to be retrieved endoscopically,
the lobes are divided into manageable pieces while being
freed from the surgical capsule. Larger fragments are then
recovered from within the bladder using a modified resec-
toscope loop that engages and holds the tissue against the
resectoscope sheath, while smaller fragments can be
removed using an Ellik evacuator.
Many centers have published HoLRP series with favorable
results [13–20] In all of these series, no patients required
transfusions or developed dilutional hyponatremia. In a
randomized trial comparing HoLRP to TURP with twoWorld Journal of Surgical Oncology 2003, 1 http://www.wjso.com/content/1/1/6
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year follow-up data, there were no significant differences
in AUA symptom scores, quality of life scores, peak flow
rates, or complications; however, TURP patients had sig-
nificantly longer mean catheterization times and hospital
stays[15]
Operative time remains an issue for HoLRP, with TURP
being completed at significantly faster rates[16] One issue
contributing to the overall length of the procedure is the
retrieval of the resected tissue. First of all, the size of the
tissue fragments is limited by the urethral caliber. In addi-
tion, the resectoscope must be removed in its entirety each
time a fragment is removed, thus slowing the process.
Questions have also been raised about the ability to
obtain accurate pathologic diagnoses with HoLRP, citing
an abundance of cauterization artifact from analyzed
specimens[21]
In order to address the previous concerns with HoLRP, a
prototype transurethral tissue morcellator was devised by
Fraundorfer and Gilling.[22] By morcellating tissue
within the bladder, the resection technique could be mod-
ified to allow complete enucleation of the median and lat-
eral lobes of the bladder, without the time-consuming
process of tailoring the lobes into manageable fragments.
This enables the surgeon to achieve a degree of tissue
removal approximating that of an open simple prostatec-
tomy while maintaining a minimally invasive nature. As
such, the latest modification of the holmium resection
technique is now known as holmium laser enucleation of
the prostate (HoLEP), combined with mechanical morcel-
lation. HoLEP can be utilized for virtually any BPH con-
figuration or size. Further, concomitant bladder calculi, if
present, are easily vaporized by the holmium laser at the
time of HoLEP. Using this technique, even the largest of
glands can be safely enucleated, with superior results
when compared to the alternative approach of open sim-
ple prostatectomy[23]. A summary of the published
HoLEP results are detailed in table 1.
Currently, we use HoLEP exclusively in our respective
institutions for the surgical treatment of BPH. The follow-
ing is a description of our HoLEP technique, detailing the
pre-operative work-up, necessary equipment, and step-
wise breakdown of the procedure.
HoLEP Technique
Pre-operative work-up
As with any surgical procedure, the HoLEP pre-operative
work-up consists of a detailed history and physical, which
should include an AUA symptom score and also a flow
rate and post-void residual to objectively document the
severity of obstruction. Laboratory tests consist of a com-
plete blood count, serum chemistries, PSA level, and uri-
nalysis with urine culture. Any PSA elevation should be
followed by appropriate prostate biopsies before proceed-
ing with HoLEP. A coagulation profile is not routinely
obtained at our institutions unless a history of bleeding
diathesis is present.
Because size estimates from digital rectal exams can be
inaccurate, obtaining a transrectal ultrasound (TRUS)
prostate volume pre-operatively is recommended. This is
an important data point, as one should aim to start with
smaller glands (i.e. < 40 cc) when first learning the proce-
dure. Further, TRUS provides a clearer estimation of the
time required for the procedure when arranging operative
schedules. In addition, flexible cystoscopy is performed
on all patients as part of their workup in order to exclude
other forms of obstruction such as urethral strictures.
Lastly, informed consent must be obtained from the
patient. Particular emphasis must be placed on the possi-
bility of retrograde ejaculation after the procedure, which
had previously been documented to occur in up to 96% of
HoLRP patients[16] and in our experience, occurs in most
HoLEP patients.
Contraindications
The only absolute contraindications to the HoLEP proce-
dure are a lack of surgical clearance from a cardiopulmo-
nary standpoint or an inability to position the patient in
the dorsolithotomy position. In general, bleeding diathe-
ses are not a contraindication to HoLEP; however, we do
not recommend treating patients with uncorrected bleed-
ing diatheses during the initial learning curve. In general,
if patients are on anti-coagulants (i.e. warfarin) for entities
where the medication can be safely stopped (deep venous
thrombosis or atrial fibrillation), they should be taken off
their medication 3–5 days prior to surgery. The medica-
tion can be restarted post-operatively at the normal dose.
When anticoagulation cannot be held (i.e. cardiac valves),
HoLEP can be performed on fully anticoagulated patients.
A list of important equipment required for HoLEP is
detailed in table 2.
Procedure
Step 1 – Urethral calibration
The patient is placed in a dorsolithotomy position, with
the thighs abducted maximally to allow appropriate
manipulation of the resectoscope during apical dissection
of the lateral lobes. After sterile preparation and draping is
completed, the patient's urethra is calibrated using Van
Buren sounds up to 30 F. Only the anterior urethra should
be calibrated and care should be taken to avoid traumatiz-
ing the prostatic lobes, which can lead to bleeding and an
impaired visual field. The urethra must be able to accept
calibration up to 30 F easily; if not, urethrotomy should
be considered to widen the distal urethra. This minimizesWorld Journal of Surgical Oncology 2003, 1 http://www.wjso.com/content/1/1/6
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the possibility of urethral stricture from subsequent resec-
toscope manipulation.
Step 2 – Insertion of the resectoscope
A 26–28 F continuous flow resectoscope is inserted into
the urethra with the Timberlake obturator. The inner
sheath, with 7 F laser fiber stabilizing catheter in place, is
then locked into the resectoscope. Because of the high
power (up to 100 W) utilized for HoLEP, a video system
is mandatory for the surgeon's optical protection. The
camera is placed on the lens, and the handpiece loosened
such that the resectoscope can be rotated easily while
holding the camera in a stationary position.
Lastly, the 550 µ laser fiber is placed. Approximately 3 to
4 inches of cladding from the distal portion of the fiber
should be stripped off. It is helpful to thread the redun-
dant portion of the fiber through mosquito clamps
attached to the drape, thus keeping it out of the surgeon's
working space. The fiber can then be inserted into the 7 F
stabilizing catheter. Normal saline irrigant is then run
through TUR tubing into the resectoscope. The outflow
valve should be connected to a piece of tubing to allow
drainage into the cystoscopy drape trap and left open, to
prevent overdistension of the bladder.
Step 3 – Visualization of the anatomy
With the resectoscope in the bladder, the urethral orifices
should be located if possible, though an extremely large
median lobe may preclude this. The resectoscope is then
pulled back into the prostatic fossa and the extent of lobar
hypertrophy assessed. Lastly, the location of the verumon-
tanum and external sphincter is confirmed. The initial
step of resection depends on the degree of median lobe
hypertrophy. If the median lobe is enlarged, it is best to
enucleate this structure first, in order to provide more
room for the lateral lobe dissection (Step 4A). If the
median lobe is not greatly enlarged, one can begin enucle-
ating a lateral lobe initially (Step 4B). The laser should be
set at an energy of 2 J and frequency of 50 Hz.
Step 4A – Enucleation of the median lobe
In the case of trilobar hypertrophy, the surgeon will be
able to visualize two sulci at approximately the 5 and 7
o'clock positions, formed by the junctions of the lateral
and median lobes (Figure 1). Beginning at the level of the
bladder neck at the 7 o'clock position, a groove is formed
by cutting with the laser along the sulcus, to a point just
lateral and proximal to the verumontanum. This groove is
deepened to the level of the surgical capsule. As the groove
is developed, it should also be undermined and widened
to allow separation of the right lateral lobe and median
lobe. The process is then repeated to create a groove at the
5 o'clock position.
During the initial learning curve, it is often difficult to dis-
cern the level of the plane between the adenoma and sur-
gical capsule when deepening the groove. To facilitate the
development of the correct plane, one should first attempt
to deepen the groove proximally, as the surgical capsule in
this region is more easily defined by its characteristic
white circular fibers (Figure 2). As the incision progresses
along the sulcus to the mid-portion of the prostatic fossa,
the level of the capsule can be more difficult to define. The
groove should end just laterally to the verumontanum. If
the surgeon is unsure about the depth of the more distal
portion of the groove, an initial undermining of the floor
of the lateral lobe just lateral to the verumontanum can
help to define the proper plane. To begin this dissection,
one should guide the laser fiber in a transverse fashion lat-
erally from the verumontanum. The beak of the resectos-
cope can then be angled under the lateral lobe as the plane
between the adenoma and the surgical capsule develops.
The appearance of the capsule here is a smooth, glistening
surface with occasional diaphanous, cobweb-like attach-
ments to the adenomatous tissue. At times, the capsule
may be thinned to the point where fat is visible. The
Table 1: Summary of HoLEP Results
Number 
of 
patients
Mean 
patient age 
(years)
Mean 
operative 
time* 
(min)
Mean 
enucleated 
tissue 
weight 
(grams)
Mean 
length of 
hospital 
stay 
(days)
Mean 
pre-op 
Qmax 
(cc/sec)
Mean 
post-op 
Qmax (cc/
sec)
Mean
pre-op AUA 
SS
Mean 
post-op 
AUA SS
Fraundorfer, et al[22] 14 72.0 98 37.5 1.1 7.0 25.2 21.2 7.2
Gilling, et al[25] 64 70.2 59.2 35.5 1.3 8.9 23.4 23.0 8.6
Moody, et al[26] 61 71.3 117 48.0 1.2 7.7 - 20.4 6.7
Gilling, et al. [27]# 43 73.8 82.5 61.8 1.2 9.0 24.8 23.5 2.8
Moody, et al. [23]# 10 74.8 197 151.0 2.1 - - 19.0 6.3
Kuntz and Lehrich[28]# 60 69.2 135.9 83.9 2.9 3.8 27.6 22.1 3.3
* Includes enucleation and morcellation time # Patients with > 100 gram prostatesWorld Journal of Surgical Oncology 2003, 1 http://www.wjso.com/content/1/1/6
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appearance of fat should alert the surgeon to continue
developing a plane just superficial to this level. However,
these areas seal post-operatively without sequela and are
not an indication to abort or shorten the procedure, as in
the case of TURP.
At this point, undermining of the median lobe is begun
just proximal to the verumontanum. The laser fiber is
swept in a transverse fashion between the two grooves,
staying in the plane between the surgical capsule and the
adenoma. As the distal portion of the median lobe begins
to separate away from the capsule, the beak of the resecto-
scope should be used as a leverage point to assist in lifting
the median lobe upward. This helps define the plane
between the adenoma and the capsule. Again, the capsule
tends to be smooth and shining, with cobweb-like attach-
ments to the adenoma. The surgeon should take care to
follow the capsule as it slopes gently anteriorly toward the
region of the bladder neck, to prevent undermining of the
trigone. Once the level of the bladder neck is reached, the
proximal attachments of the median lobe are freed, and
the entire median lobe is pushed into the bladder.
Step 4B – Separation of the right lobe from the capsular floor
If the median lobe does not have significant hypertrophy,
a midline groove can be created at the 6 o'clock position
beginning at the bladder neck and ending just proximal to
the verumontanum. Again, the groove should be defined
initially with the tip of the laser fiber and then widened
and deepened down to the level of the surgical capsule.
Dissection of the right lobe can then be performed by pro-
ceeding lateral to the verumontanum in a transverse fash-
ion. Once the initial plane is developed under the right
lobe, the surgeon continues in a proximal direction, free-
ing the lateral lobe from the capsular floor by moving the
laser fiber in a transverse, side-to-side motion while using
the beak of the resectoscope to leverage the lobe upwards.
It is important to avoid rotating the resectoscope too early,
as this will cause the fiber tip to arc into the adenoma pre-
maturely and potentially cause loss of plane definition.
Step 5 – Right apical and lateral dissection (from floor)
The plane between the capsular floor and right lobe
should be developed proximally toward the bladder. At
some point, the surgeon will notice that leverage under
the lateral lobe is impaired by the lateral attachments of
the lobe, making further proximal progression difficult.
Dissection should then proceed to detach the lateral
attachments near the apex of the right lateral lobe.
The laser settings are adjusted to a power of 2 J and fre-
quency of 40 Hz during the process of apical dissection, to
prevent thermal injury to the sphincter. The resectoscope
is retracted distally, and the location of the external ure-
thral sphincter confirmed by visualizing the area where
urethral coaptation occurs. After moving the resectoscope
proximally to the sphincter, the most lateral point of the
previously dissected plane between the floor and right
lobe is located. Dissection in this plane is continued, this
time staying between the apical tissue of the right lobe
and the capsule by rotating the resectoscope in a clockwise
direction during cutting. There is limited space for the tip
of the resectoscope during this portion of the dissection,
restricting the field of view. Therefore, the tip of the laser
fiber should be retracted to the point where it is barely vis-
ible. The arcing motion of the fiber tip should follow the
Table 2: Essential equipment list
Video tower and camera
Holmium laser unit (must have 80–100 watt maximum power)
550 µ holmium laser fiber
550 µ laser fiber stripper
26 to 28 F continuous flow resectoscope sheath with modified inner 
sheath (containing laser fiber stabilizing bridge)
30 degree cystoscope lens
7 F laser fiber stabilizing catheter (Cook Urological, Incorporated, 
Spencer, Indiana)
Van Buren sounds
Ellik evacuator
Stone basket, model FG-24SX-1 (Olympus)
11 F Alligator grasper (Karl Storz)
Offset rigid nephroscope (Karl Storz)
Morcellator (Lumenis)
Normal saline irrigant (3 liter bags)
20 F, 2-way Foley catheter (30 cc balloon)
Catheter guide
Figure 1
Sulci between median and lateral lobes (at 5 and 7 o'clock)World Journal of Surgical Oncology 2003, 1 http://www.wjso.com/content/1/1/6
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curve of the surgical capsule as it progresses laterally. It is
important to begin the dissection at a point slightly
proximal to the apex, in order to leave behind an "apical
pad" of tissue that helps protect the integrity of the
sphincter (Figure 3).
Once definition of the apical tissue has begun, the beak of
the resectoscope is again guided under the lip of the apex
to leverage the adenoma away during dissection. The lat-
eral dissection should proceed up to approximately the 9
to 10 o'clock position, with smaller glands allowing more
lateral freedom. The lateral wall of the right lobe should
then be freed from the surgical capsule by proceeding
proximally along the already defined plane. At this point,
the surgeon should be rotating the resectoscope in alter-
nating clockwise and counterclockwise directions, which
causes the tip of the laser fiber to proceed in a smooth arc
back and forth within the established plane. The dissec-
tion should be continued until difficulty is encountered
with exposure of the plane proximally. As much of the
lateral lobe is dissected away from the bladder neck area
as possible, to facilitate the final steps of the enucleation.
Step 6 – Creation of anterior groove
Attention is turned to the 12 o'clock region of the prostatic
fossa, where the anterior commisure (midline groove
between lateral lobes) is located. The resectoscope is
turned 180° to allow the laser fiber to be positioned cor-
rectly. Laser settings should be adjusted back to 2 J and 50
Hz. Beginning at the bladder neck and proceeding dis-
tally, a groove is cut along the anterior commisure. This
groove should span from the level of the bladder neck to
the level of the verumontanum. The surgeon should occa-
sionally reconfirm the location of the verumontanum by
looking toward the floor, to ensure that the groove is not
extended too far distally. Once the groove is created, it is
again widened and deepened to the level of the surgical
capsule along its entire extent.
Step 7 – Separation of right lobe from roof of capsule
The tip of the laser fiber should be angled toward the
plane between the adenoma and the capsule. Initially, the
fiber should be directed along the plane proximally and
distally in a sequential fashion to begin dividing the ante-
rior attachments of the right lobe. It is helpful for the dis-
section to begin at the bladder neck, where capsular
definition is much easier (Figure 4). The attachments
between the anterior portion of the lobe and the capsule
are taken down sequentially until the lateral extent of the
lobe is reached.
Step 8 – Dissection and release of lateral portion of right lobe
It is crucial at this stage to identify the extent of the
remaining lateral attachments near the apex of the lobe.
This process can be difficult, as the planes of dissection
between the adenoma and capsule from the anterior and
posterior vectors may not join at the same level laterally.
It is helpful to gain perspective by guiding the resectos-
cope first along the anterior plane and then the posterior
plane, to fully visualize the lateral extent of each. Once the
junction between the planes is defined, usually by a
mucosal strip or bridge (Figure 5), it is cut by the laser to
join the planes. Laser settings are 2 J and 40 Hz during
division of the mucosal strip. The surgeon can then con-
Figure 2
Appearance of proximal surgical capsule
Figure 3
Appearance of left apical padWorld Journal of Surgical Oncology 2003, 1 http://www.wjso.com/content/1/1/6
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tinue the dissection proximally, at 2 J and 50 Hz, to free
the lateral extent of the lobe.
Step 9 – Completion of right lobe enucleation
At this point, the right lobe will be held only by attach-
ments at the bladder neck level. The anterior attachments
at the bladder neck should already have been divided. By
following this plane further laterally, any remaining
attachments in this area can be freed. Finally, one should
proceed under the lobe and finish dividing attachments at
the floor of the capsule and the posterior bladder neck.
The lobe can then be pushed into the bladder by leverag-
ing upward with the beak of the resectoscope (Figure 6).
Care should be taken to avoid injuring the bladder neck
during this process, which can occur if the resectoscope
beak is inadvertently pushed too posteriorly.
Step 10 – Enucleation of the left lobe
The left lateral side of the 5 o'clock groove (or 6 o'clock
groove in cases where the median lobe did not require
enucleation) is undermined, beginning at the bladder
neck level and progressing distally. This begins separation
of the posterior portion of the lateral lobe from the capsu-
lar floor. The plane between the left lobe and the floor of
the surgical capsule is further defined by cutting laterally
from the verumontanum in a transverse fashion. The beak
of the resectoscope can then be used to provide leverage
under the lateral lobe while division of the posterior
attachments is continued. Dissection of the left lobe apex,
anterior portion of the lobe, connection of the planes lat-
erally, and division of the remaining attachments at the
bladder neck are done as previously described.
Step 11 – Inspection of the prostatic fossa
Once all lobes have been dissected free and pushed into
the bladder, the laser settings should be changed to 2.5 J
and 40 Hz (for large bleeders) or 1.5 J and 30 Hz (for
smaller bleeders and near apex) to achieve optimal coag-
ulation. The capsular surface is then inspected carefully.
Any capsular bleeders should be coagulated by first defo-
cusing the laser (positioning tip of the fiber 2–3 mm away
from the surface) and then activating it until hemostasis is
achieved. A dry fossa is essential before beginning
morcellation to optimize visualization and minimize the
risk of bladder injury. If any residual portions of adenoma
remain along the surface of the capsule, these can be easily
vaporized or enucleated with the laser.
Step 12 – Morcellation
The inner sheath of the resectoscope along with the laser
fiber and stabilizing catheter are removed. The rigid offset
nephroscope is then inserted into the outer resectoscope
sheath. We utilize a commercially available morcellator
(VersaCut, Lumenis Incorporated, Santa Clara, CA) con-
sisting of a set of hollow reciprocating blades (5 mm
diameter shaft) attached to a handle apparatus (Figure 7).
Offset nephroscopes with a 5 mm working channel (Karl
Storz, Olympus) are required to accommodate the mor-
cellator. Olympus is the only manufacturer with a pur-
pose-built device for HoLEP and morcellation. A vacuum
pump is connected to the morcellator handle to provide
suction through the blades, and device activation control-
led through a foot pedal. Inflow tubing with normal
Figure 4
Dissection of plane between anterior surgical capsule and 
adenoma
Figure 5
Appearance of mucosal strip (to left)World Journal of Surgical Oncology 2003, 1 http://www.wjso.com/content/1/1/6
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saline should be connected to both inflow ports (outer
resectoscope sheath, rigid nephroscope) to ensure that the
bladder remains distended during the morcellation proc-
ess. This is crucial, as collapse of the bladder can lead to
significant injury to the bladder wall.
Under direct visualization, the tip of the morcellator is
inserted into the bladder and guided beneath a portion of
adenoma. The pedal is then depressed partially to trigger
the suction. Once a portion of adenoma is engaged by the
morcellator, the pedal is fully depressed to activate the
blades. It is important to keep the tip of the morcellator
anteriorly within the bladder and within the visual field at
all times. The morcellator shaft should be moved in and
out of the working channel in small increments and
rotated at times, to optimize engagement of tissue. When
the remaining tissue pieces are small, the surgeon should
engage them with suction alone and pull them into the
prostatic fossa, where morcellation can be done safely by
pinning the tissue against the capsule. If difficulty is
encountered in engaging these smaller pieces, the
Olympus stone basket (Olympus America Incorporated,
Melville, NY) or 11F Alligator forceps can be used to facil-
itate their removal. Lastly, the Ellik evacuator is utilized to
remove any remaining pieces of adenoma or clot. The
patient is then given 20 mg of furosemide intravenously
to promote urine flow during the immediate post-opera-
tive period. If the procedure has been long or the capsule
is thin, it is advisable to give another 20 mg of furosemide
intraoperatively to avoid fluid overload. On occasion, a
smooth surfaced portion of adenoma fails to engage in
the morcellator. If it is too large to be removed with the
basket or forceps, the adenoma should be moved into the
prostatic fossa. It can then be incised at different points
with the laser fiber, providing more surface area for mor-
cellator engagement without the risk of bladder injury.
As a option to morcellation, other investigators have
described a modified tissue retrieval technique where an
enucleated prostate lobe is initially left attached at the
bladder neck by a small pedicle[24] A TUR electrocautery
loop is subsequently utilized to resect the lobe into pieces
retrievable with an evacuator. While this alternative obvi-
ates the need for a mechanical morcellator, the median
prostate volume of the patient cohort treated with this
technique was only 38 ml. Overall, we believe that the
morcellator remains the most efficient method of tissue
removal following enucleation. By employing the safety
measures described earlier, morcellation can be per-
formed in a safe manner with little chance of morbidity.
A 20 F, 3-way Foley catheter is placed at the conclusion of
the case with the aid of a catheter guide. As continuous
bladder irrigation is seldom required, the third port is
plugged; however, it remains available should the need
for irrigation arise. Currently, patients have their catheters
removed early the following morning. HoLEP can be per-
formed as an outpatient or overnight (i.e. short stay) pro-
cedure, depending on patient preference.
Conclusions
Worldwide experience with the HoLEP technique has
shown the procedure to be a safe and effective alternative
for the surgical treatment of BPH. Although enucleation
of prostate adenoma can be performed by a variety of
energy sources, only the holmium laser possesses the ideal
Figure 6
Use of resectoscope beak to leverage adenoma upward
Figure 7
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combination of cutting and coagulation. As a result, the
risk of dilutional hyponatremia and the need for
transfusion are essentially eliminated. Hospital stays are
minimal, and almost all patients are able to be discharged
catheter-free. Although the learning curve for this proce-
dure remains steep, the subsequent patient advantages
should continue to expand the appeal and usage of the
HoLEP technique within the urologic community. This
technique has the potential to become the standard for
surgical management of BPH.
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